{
  "@context": "https://schema.org",
  "@id": "https://aggr.aymericbeaumet.com/items/youtube-com-arstechnica/2024-10-30-ars-live-the-rise-of-glp-1-drugs-insights-and-unknowns/#webpage",
  "@type": [
    "WebPage",
    "ArchiveComponent"
  ],
  "articleBody": "Ars Technica Senior Health Reporter Dr. Beth Mole is joined by Dr. Daniel J Drucker, MD, FRCPC from the Lunenfeld Tanenbaum Research Institute for a discussion on the implications, insights, and unknowns around the proliferation and rapid adoption of GLP-1 drugs.\n",
  "authors": [
    "Ars Technica"
  ],
  "captured_at": "2026-09-08T10:17:10.166315+00:00",
  "category": "science",
  "content_html": "<p>Ars Technica Senior Health Reporter Dr. Beth Mole is joined by Dr. Daniel J Drucker, MD, FRCPC from the Lunenfeld Tanenbaum Research Institute for a discussion on the implications, insights, and unknowns around the proliferation and rapid adoption of GLP-1 drugs.</p>\n",
  "content_markdown": "Ars Technica Senior Health Reporter Dr. Beth Mole is joined by Dr. Daniel J Drucker, MD, FRCPC from the Lunenfeld Tanenbaum Research Institute for a discussion on the implications, insights, and unknowns around the proliferation and rapid adoption of GLP-1 drugs.\n",
  "dateCreated": "2026-09-08T10:17:10.166315+00:00",
  "date_created": "2024-10-30T14:54:22+00:00",
  "date_modified": "2026-05-21T02:30:19+00:00",
  "date_published": "2024-10-30T14:54:22+00:00",
  "description": "Ars Technica Senior Health Reporter Dr. Beth Mole is joined by Dr. Daniel J Drucker, MD, FRCPC from the Lunenfeld Tanenbaum Research Institute for a discussion on the implications, insights, and unknowns around the proliferation and rapid…",
  "external_url": "https://www.youtube.com/watch?v=eLI6dYmtmGo",
  "git": {
    "commit": "ebb0941c5c06a2ab2377342d607535262a3e969e",
    "path": "items/youtube-com-arstechnica/2024/10/2024-10-30-ars-live-the-rise-of-glp-1-drugs-insights-and-unknowns.md",
    "permalink": "https://github.com/aymericbeaumet/aggr-instance/blob/ebb0941c5c06a2ab2377342d607535262a3e969e/items/youtube-com-arstechnica/2024/10/2024-10-30-ars-live-the-rise-of-glp-1-drugs-insights-and-unknowns.md"
  },
  "id": "urn:aggr:item:a3accb7df409a6abb13aad3225b86f4c2574c004",
  "isBasedOn": {
    "@id": "https://www.youtube.com/watch?v=eLI6dYmtmGo"
  },
  "mainEntity": {
    "@id": "https://www.youtube.com/watch?v=eLI6dYmtmGo",
    "@type": "CreativeWork",
    "archivedAt": {
      "@id": "https://aggr.aymericbeaumet.com/items/youtube-com-arstechnica/2024-10-30-ars-live-the-rise-of-glp-1-drugs-insights-and-unknowns/#webpage"
    },
    "author": [
      {
        "@type": "Person",
        "name": "Ars Technica"
      }
    ],
    "dateModified": "2026-05-21T02:30:19+00:00",
    "datePublished": "2024-10-30T14:54:22+00:00",
    "headline": "Ars Live: The rise of GLP-1 drugs: Insights and Unknowns",
    "timeRequired": "PT1M",
    "url": "https://www.youtube.com/watch?v=eLI6dYmtmGo",
    "wordCount": 42
  },
  "name": "Archived snapshot: Ars Live: The rise of GLP-1 drugs: Insights and Unknowns",
  "preview": null,
  "reading_minutes": 1,
  "replicated_at": null,
  "source": "youtube-com-arstechnica",
  "source_name": "Ars Technica",
  "summary": "Ars Technica Senior Health Reporter Dr. Beth Mole is joined by Dr. Daniel J Drucker, MD, FRCPC from the Lunenfeld Tanenbaum Research Institute for a discussion on the implications, insights, and unknowns around the proliferation and rapid adoption of GLP-1 drugs.",
  "tags": [],
  "temporalCoverage": "2026-09-08T10:17:10.166315+00:00",
  "title": "Ars Live: The rise of GLP-1 drugs: Insights and Unknowns",
  "url": "https://aggr.aymericbeaumet.com/items/youtube-com-arstechnica/2024-10-30-ars-live-the-rise-of-glp-1-drugs-insights-and-unknowns/",
  "word_count": 42
}